Recent Finacing
Recent Raise
ReNAgade develops an all‑RNA therapeutic platform combining proprietary lipid nanoparticle delivery technologies with coding, editing, and gene‑insertion tools to enable RNA delivery to previously inaccessible tissues.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at ReNAgade Therapeutics.
